Literature DB >> 15709839

Can the randomized controlled trial literature generalize to nonrandomized patients?

Shannon Wiltsey Stirman1, Robert J Derubeis, Paul Crits-Christoph, Allison Rothman.   

Abstract

To determine the extent to which published randomized controlled trials (RCTs) of psychotherapy can be generalized to a sample of outpatients, the authors matched information obtained from charts of patients who had been screened out of RCTs to inclusion and exclusion criteria from published RCT studies. Most of the patients in the sample who had primary diagnoses represented in the RCT literature were judged eligible for at least 1 RCT. However, many patients in the sample with substance use disorders or social anxiety disorder were not eligible for at least 2 RCTs. Common reasons that patients did not match with at least 2 published RCTs for psychotherapy included (a) patients were in partial remission, (b) patients failed to meet minimum severity or duration criteria, (c) patients were being treated with antidepressant medication, and (d) the disorder being studied was not primary (mostly for social anxiety patients). The implications of these findings for future research and clinical practice are discussed. Copyright 2005 APA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15709839     DOI: 10.1037/0022-006X.73.1.127

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  19 in total

1.  Training Therapists in Evidence-Based Practice: A Critical Review of Studies From a Systems-Contextual Perspective.

Authors:  Rinad S Beidas; Philip C Kendall
Journal:  Clin Psychol (New York)       Date:  2010-03

2.  Representativeness of patients enrolled in influential clinical trials: a comparison of substance dependence with other medical disorders.

Authors:  Keith Humphreys; Natalya C Maisel; Janet C Blodgett; John W Finney
Journal:  J Stud Alcohol Drugs       Date:  2013-11       Impact factor: 2.582

3.  Generalizing Treatment Effect Estimates From Sample to Population: A Case Study in the Difficulties of Finding Sufficient Data.

Authors:  Elizabeth A Stuart; Anna Rhodes
Journal:  Eval Rev       Date:  2016-08-04

4.  Theoretical and practical barriers to practitioners' willingness to seek training in empirically supported treatments.

Authors:  Rebecca E Stewart; Dianne L Chambless; Jonathan Baron
Journal:  J Clin Psychol       Date:  2011-09-07

5.  Generalizability of randomized trial results to target populations: Design and analysis possibilities.

Authors:  Elizabeth A Stuart; Benjamin Ackerman; Daniel Westreich
Journal:  Res Soc Work Pract       Date:  2017-07-27

6.  Improving Depression Among HIV-Infected Adults: Transporting the Effect of a Depression Treatment Intervention to Routine Care.

Authors:  Angela M Bengtson; Brian W Pence; Bradley N Gaynes; E Byrd Quinlivan; Amy D Heine; Julie K OʼDonnell; Heidi M Crane; W Christopher Mathews; Richard D Moore; Daniel Westreich; Conall OʼCleirigh; Katerina Christopoulos; Matthew J Mimiaga; Michael J Mugavero
Journal:  J Acquir Immune Defic Syndr       Date:  2016-12-01       Impact factor: 3.731

7.  The applicability of randomized controlled trials of psychosocial treatments for PTSD to a veteran population.

Authors:  Shannon Wiltsey Stirman
Journal:  J Psychiatr Pract       Date:  2008-07       Impact factor: 1.325

8.  Empirically supported treatments in rural community mental health centers: a preliminary report on current utilization and attitudes toward adoption.

Authors:  John Paul Jameson; Dianne L Chambless; Michael B Blank
Journal:  Community Ment Health J       Date:  2009-12

9.  Cognitive-behavioral therapy for adult anxiety disorders in clinical practice: a meta-analysis of effectiveness studies.

Authors:  Rebecca E Stewart; Dianne L Chambless
Journal:  J Consult Clin Psychol       Date:  2009-08

10.  Is implementation of the care transitions intervention associated with cost avoidance after hospital discharge?

Authors:  Rebekah Gardner; Qijuan Li; Rosa R Baier; Kristen Butterfield; Eric A Coleman; Stefan Gravenstein
Journal:  J Gen Intern Med       Date:  2014-03-04       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.